Manufacturing Process: The efficiency and scalability of Novavax's vaccine manufacturing significantly impact investor confidence and the stock price.

Clinical Trial Results: Positive data from ongoing clinical trials for new vaccine formulations or indications can drive the price upwards.

Regulatory Approvals: Approvals from major regulatory bodies such as the FDA or EMA are crucial for market access and influence the stock price positively.

Competitive Landscape: The presence of other vaccine manufacturers and the emergence of new technologies affect Novavax's market share and valuation.

Government Contracts: Large supply agreements with governments worldwide contribute significantly to revenue and boost investor sentiment.

Global Health Crises: Public health emergencies and the demand for vaccines influence the stock price as seen during the COVID-19 pandemic.

Production Capacity: The ability to meet the demand for vaccines directly impacts revenue and investor perception of the company's value.

Intellectual Property: Patents and exclusive rights protect Novavax's technology, impacting its long-term value and attracting investors.

Financial Performance: Revenue, profitability, and cash flow determine the financial health and influence investor decisions.

Investor Sentiment: General market trends and overall investor optimism affect the demand for stocks including NVAK.F.

News and Media: Media coverage and public perception can create volatility in the stock price.

Alternative Investments: The availability of alternative investment opportunities influences investors' decision to buy or sell NVAK.F stock.

Supply Chain Issues: Disruptions in the supply chain for raw materials and equipment affect production and the stock price.

Management Team: The competence and strategic decisions of the management team affect investor confidence and the company's overall direction.

Technological Advances: Innovations in vaccine technology can positively or negatively affect the demand for Novavax's products.

Currency Exchange Rates: Exchange rate fluctuations can affect revenue and profits, especially for companies operating globally.

Interest Rates: Interest rate changes can affect the cost of borrowing and the overall valuation of the company.

Economic Growth: Economic growth in key markets can increase vaccine demand and affect revenue.

Political Stability: Political instability in regions where Novavax operates or sells its products can disrupt operations and affect the stock price.

Insurance Coverage: The extent of insurance coverage for Novavax vaccines impacts market accessibility and demand.